427 related articles for article (PubMed ID: 22439934)
1. The crosstalk of mTOR/S6K1 and Hedgehog pathways.
Wang Y; Ding Q; Yen CJ; Xia W; Izzo JG; Lang JY; Li CW; Hsu JL; Miller SA; Wang X; Lee DF; Hsu JM; Huo L; Labaff AM; Liu D; Huang TH; Lai CC; Tsai FJ; Chang WC; Chen CH; Wu TT; Buttar NS; Wang KK; Wu Y; Wang H; Ajani J; Hung MC
Cancer Cell; 2012 Mar; 21(3):374-87. PubMed ID: 22439934
[TBL] [Abstract][Full Text] [Related]
2. The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling.
Diao Y; Rahman MF; Villegas VE; Wickström M; Johnsen JI; Zaphiropoulos PG
BMC Cancer; 2014 Aug; 14():600. PubMed ID: 25134527
[TBL] [Abstract][Full Text] [Related]
3. Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade.
Wang W; Yan T; Guo W; Niu J; Zhao Z; Sun K; Zhang H; Yu Y; Ren T
Cell Death Differ; 2021 Jul; 28(7):2221-2237. PubMed ID: 33637972
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
[TBL] [Abstract][Full Text] [Related]
5. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer.
Wei L; Xu Z
Int J Cancer; 2011 Jul; 129(2):275-84. PubMed ID: 20839260
[TBL] [Abstract][Full Text] [Related]
6. DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.
Singh R; Dhanyamraju PK; Lauth M
Oncotarget; 2017 Jan; 8(1):833-845. PubMed ID: 27903983
[TBL] [Abstract][Full Text] [Related]
7. ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.
Kebenko M; Drenckhan A; Gros SJ; Jücker M; Grabinski N; Ewald F; Grottke A; Schultze A; Izbicki JR; Bokemeyer C; Wellbrock J; Fiedler W
Cell Signal; 2015 Feb; 27(2):373-81. PubMed ID: 25435423
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers.
Gan GN; Eagles J; Keysar SB; Wang G; Glogowska MJ; Altunbas C; Anderson RT; Le PN; Morton JJ; Frederick B; Raben D; Wang XJ; Jimeno A
Cancer Res; 2014 Dec; 74(23):7024-36. PubMed ID: 25297633
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines.
Mizuarai S; Kawagishi A; Kotani H
Mol Cancer; 2009 Jul; 8():44. PubMed ID: 19575820
[TBL] [Abstract][Full Text] [Related]
10. GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway.
Yao Y; Zhou D; Shi D; Zhang H; Zhan S; Shao X; Sun K; Sun L; Wu G; Tian K; Zhu X; He S
Biomed Pharmacother; 2019 Mar; 111():993-1004. PubMed ID: 30841479
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone inhibits tumor necrosis factor-α-induced migration and invasion through AKT/mTOR/S6k1/hedgehog signaling in human breast cancer.
Qiu S; Zhou Y; Kim JT; Bao C; Lee HJ; Chen J
Food Funct; 2021 Oct; 12(20):10196-10209. PubMed ID: 34542136
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
13. S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer.
Nawroth R; Stellwagen F; Schulz WA; Stoehr R; Hartmann A; Krause BJ; Gschwend JE; Retz M
PLoS One; 2011; 6(11):e27509. PubMed ID: 22110663
[TBL] [Abstract][Full Text] [Related]
14. The Plk1 kinase negatively regulates the Hedgehog signaling pathway by phosphorylating Gli1.
Zhang T; Xin G; Jia M; Zhuang T; Zhu S; Zhang B; Wang G; Jiang Q; Zhang C
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30578313
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
[TBL] [Abstract][Full Text] [Related]
16. MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
Lu J; Liu L; Zheng M; Li X; Wu A; Wu Q; Liao C; Zou J; Song H
Oncogene; 2018 Jul; 37(28):3864-3878. PubMed ID: 29662197
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog Signaling and Truncated GLI1 in Cancer.
Doheny D; Manore SG; Wong GL; Lo HW
Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the sonic hedgehog pathway cause macrocephaly-associated conditions due to crosstalk to the PI3K/AKT/mTOR pathway.
Klein SD; Nguyen DC; Bhakta V; Wong D; Chang VY; Davidson TB; Martinez-Agosto JA
Am J Med Genet A; 2019 Dec; 179(12):2517-2531. PubMed ID: 31639285
[TBL] [Abstract][Full Text] [Related]
19. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling.
Shimokawa T; Rahman MF; Tostar U; Sonkoly E; Ståhle M; Pivarcsi A; Palaniswamy R; Zaphiropoulos PG
RNA Biol; 2013 Feb; 10(2):321-33. PubMed ID: 23324600
[TBL] [Abstract][Full Text] [Related]
20. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
